MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure
Gespeichert in:
| Weitere Verfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Leukemia
Year: 2014, Jahrgang: 28, Heft: 7, Pages: 1478-1485 |
| ISSN: | 1476-5551 |
| Online-Zugang: | Verlag, Volltext: http://www.nature.com/leu/journal/v28/n7/full/leu20146a.html |
| Verfasserangaben: | Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha, D.; Woodman, R. C.; Hofmann, W-K; Hehlmann, R.; Hochhaus, A.; Mueller, M. C. |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1518854184 | ||
| 003 | DE-627 | ||
| 005 | 20220812093159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 151027s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2014.6 |2 doi | |
| 035 | |a (DE-627)1518854184 | ||
| 035 | |a (DE-576)44885418X | ||
| 035 | |a (DE-599)BSZ44885418X | ||
| 035 | |a (OCoLC)1340717013 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure |c Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha, D.; Woodman, R. C.; Hofmann, W-K; Hehlmann, R.; Hochhaus, A.; Mueller, M. C. |
| 264 | 1 | |c 2014 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 27.10.2015 | ||
| 700 | 1 | |a Agrawal, Mridul |d 1987- |0 (DE-588)1078043094 |0 (DE-627)837981689 |0 (DE-576)448891107 |4 oth | |
| 700 | 1 | |a Hanfstein, Benjamin |d 1971- |0 (DE-588)143353519 |0 (DE-627)645128228 |0 (DE-576)336605587 |4 oth | |
| 700 | 1 | |a Erben, Philipp |d 1973- |0 (DE-588)128501014 |0 (DE-627)373920997 |0 (DE-576)297181661 |4 oth | |
| 700 | 1 | |a Fabarius, Alice |d 1965- |0 (DE-588)1037001281 |0 (DE-627)751728314 |0 (DE-576)390896667 |4 oth | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 oth | |
| 700 | 1 | |a Hofmann, Wolf-Karsten |d 1967- |0 (DE-588)114154635 |0 (DE-627)691208751 |0 (DE-576)351568336 |4 oth | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 oth | |
| 700 | 1 | |a Müller, Martin Christian |d 1972- |0 (DE-588)121360296 |0 (DE-627)705409236 |0 (DE-576)181482819 |4 oth | |
| 773 | 0 | 8 | |i In |t Leukemia |d London : Springer Nature, 1997 |g 28(2014), 7, Seite 1478-1485 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure |
| 773 | 1 | 8 | |g volume:28 |g year:2014 |g number:7 |g pages:1478-1485 |g extent:8 |a MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure |
| 856 | 4 | 0 | |u http://www.nature.com/leu/journal/v28/n7/full/leu20146a.html |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20151027 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 121360296 |a Müller, Martin Christian |m 121360296:Müller, Martin Christian |d 60000 |d 61200 |e 60000PM121360296 |e 61200PM121360296 |k 0/60000/ |k 1/60000/61200/ |p 13 |y j | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |e 60000PH1037003489 |k 0/60000/ |p 11 | ||
| 998 | |g 114154635 |a Hofmann, Wolf-Karsten |m 114154635:Hofmann, Wolf-Karsten |d 60000 |d 61200 |e 60000PH114154635 |e 61200PH114154635 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |e 60000PS115839860 |e 61200PS115839860 |k 0/60000/ |k 1/60000/61200/ |p 7 | ||
| 998 | |g 1037001281 |a Fabarius, Alice |m 1037001281:Fabarius, Alice |d 60000 |d 61200 |e 60000PF1037001281 |e 61200PF1037001281 |k 0/60000/ |k 1/60000/61200/ |p 6 | ||
| 998 | |g 128501014 |a Erben, Philipp |m 128501014:Erben, Philipp |d 60000 |d 61200 |e 60000PE128501014 |e 61200PE128501014 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 143353519 |a Hanfstein, Benjamin |m 143353519:Hanfstein, Benjamin |d 60000 |d 61200 |e 60000PH143353519 |e 61200PH143353519 |k 0/60000/ |k 1/60000/61200/ |p 2 | ||
| 998 | |g 1078043094 |a Agrawal, Mridul |m 1078043094:Agrawal, Mridul |d 60000 |d 61200 |e 60000PA1078043094 |e 61200PA1078043094 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1518854184 |e 286924438X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure","title_sort":"MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure"}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha, D.; Woodman, R. C.; Hofmann, W-K; Hehlmann, R.; Hochhaus, A.; Mueller, M. C."]},"note":["Gesehen am: 27.10.2015"],"id":{"doi":["10.1038/leu.2014.6"],"eki":["1518854184"]},"recId":"1518854184","origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Mridul","display":"Agrawal, Mridul","family":"Agrawal","role":"oth"},{"given":"Benjamin","family":"Hanfstein","display":"Hanfstein, Benjamin","role":"oth"},{"display":"Erben, Philipp","family":"Erben","role":"oth","given":"Philipp"},{"family":"Fabarius","display":"Fabarius, Alice","role":"oth","given":"Alice"},{"given":"Susanne","role":"oth","family":"Saußele","display":"Saußele, Susanne"},{"family":"Hofmann","display":"Hofmann, Wolf-Karsten","role":"oth","given":"Wolf-Karsten"},{"display":"Hehlmann, Rüdiger","family":"Hehlmann","role":"oth","given":"Rüdiger"},{"family":"Müller","display":"Müller, Martin Christian","role":"oth","given":"Martin Christian"}],"relHost":[{"part":{"extent":"8","year":"2014","issue":"7","text":"28(2014), 7, Seite 1478-1485","pages":"1478-1485","volume":"28"},"disp":"MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failureLeukemia","pubHistory":["Nachgewiesen 11.1997 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"32046699X","title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 15.03.04"],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-"}]}]} | ||
| SRT | |a MDR1EXPRES2014 | ||